cyclopentane has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aspichueta, P; Azkargorta, M; Banales, JM; Bujanda, L; Caballero-Camino, FJ; Drenth, JPH; Elortza, F; Izquierdo-Sanchez, L; Lee-Law, PY; Martinez-Chantar, ML; Marzioni, M; Olaizola, P; Perugorria, MJ; Rodrigues, PM | 1 |
1 other study(ies) available for cyclopentane and Liver Dysfunction
Article | Year |
---|---|
Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease.
Topics: Animals; Apoptosis; Bile Ducts; Cell Proliferation; Cell Survival; Cyclopentanes; Cysts; Enzyme Inhibitors; Humans; Liver Diseases; NEDD8 Protein; Protein Processing, Post-Translational; Pyrimidines; Rats; Sumoylation; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Up-Regulation | 2021 |